Search

everythinglearnresearchcommunity

for

Search:↓

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Combining cosmetic procedures with lifestyle changes improves antiaging results.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

A 15-year-old girl with no menstrual period was diagnosed with a genetic condition that makes her body unable to respond to male hormones, leading to female characteristics despite having male genetic makeup.

New therapies are being developed that target integrin pathways to treat various diseases.

Combination of 17α-estradiol and minoxidil improves hair growth and reduces hair loss in most patients.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Isotretinoin is a preferred treatment for severe acne, often leading to long-term improvement, but requires careful monitoring due to potential side effects.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Nutraceuticals may improve skin health and protect against aging, but more research is needed on their optimal use and possible health risks.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

Testosterone improves mood and thinking skills; finasteride has no effect.

The document concludes that various skin conditions have specific treatments and that adequate calcium intake may prevent osteoporosis.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Hair loss from mood stabilizers is common but can be managed without stopping the medication.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

A 14-year-old girl with no menstrual period was diagnosed with Swyer Syndrome and treated for a related cancer risk.

Balding men had lower bone density, while balding women had higher hip bone density.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

A girl's hair-pulling condition improved greatly after she started vitamin D treatment.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.